RESEARCH
Evidence-based practice is the key to providing safe and responsible neurologic care in the fields of medical cannabis & psychedelic therapy.
Dr. Lewis believes quality evidence derives from quality research.
Visit CRIS here
Cannabinoid Research Initiative Of Saskatchewan (CRIS)
As a contributing member of CRIS, Dr. Lewis has assisted in the development of various research initiatives. He is a principal applicant on a CRIS proposal for a major national and international clinical trial in the treatment of epilepsy with medical cannabis with an aim to begin in 2021. The Neurology Centre of Toronto is planing to be a primary site for this trial.
Canadian Childhood Cannabinoid Clinical trials (C4T)
Dr. Lewis is a member of C4T, a national research group focused on the development of clinical trials in cannabis for children. At present, Dr. Lewis is co-investigator and site lead for a clinical trial testing the safety of medical cannabis to treat chronic headache in adolescents. He is also the co-investigator on an upcoming randomized control trial testing CBD and CBD/THC cannabis oils against placebo for the treatment of drug-resistant epilepsy in children and adults.
Visit C4T here
Current research Interests in Cannabis & Psychedelics:
Drug-Resistant Epilepsy (Adults & Children)
Chronic Headache (Children aged 12 - 17 years)
Functional Neurologic Disorders
Functional Seizures (aka: Psychogenic Non-Epileptic Seizures - PNES)
Psychedelic-Assisted Therapies in the Context of Neurologic Conditions